Researchers at Yale School of Medicine implemented clinical patient safety interventions to standardize communication and interpretation of fetal monitoring, leading to a 60% decrease in adverse events over 2.5 years. The staff's perception of the safety climate also increased by 30%.
Ustekinumab therapy maintains clinically meaningful improvement in moderate to severe plaque psoriasis through 1 year, with 87% and 91% of patients sustaining a 75% PASI improvement. The study also found sustained response rates at 66% and 73% for PASI 90.
A study by Yale University researchers has identified a gene, ENPP1, linked to preterm birth and low birth weight in Hispanic women. The study found that this variant of the gene may be associated with deranged energy metabolism, a possible explanation for preterm births.